ZLAB
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease – Zai Lab Limited
Wednesday, March 27, 2024 1 min read
Key Takeaway: argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease – Zai Lab Limited
Full Press Release Details
argenx Advances Clinical Development of Efgartigimod in Primary Sjogren’s Disease – Zai Lab Limited.